C
CellFE
Biotech & Life Sciences · Alameda, United States · Founded 2018
Company developing a microfluidics based device to deliver gene-editing molecules MoreLess
CellFE is a biotechnology company focused on advancing cell therapies through innovative microfluidic cellular engineering technology. The company serves advanced cell therapy researchers and developers, operating in the biotechnology and healthcare markets. CellFE's business model revolves around providing cutting-edge solutions that enhance the manufacturing process of cell therapies, making them more potent, durable, and cost-effective. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary technology. The company is dedicated to supporting cell therapy innovators in producing superior treatments for patients worldwide, leveraging a team of seasoned biotech experts and inventors.
Keywords: microfluidic technology, cell therapy, biotechnology, healthcare, manufacturing, cost-effective, potent treatments, durable therapies, partnerships, licensing.
Talent graph
CellFE's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where CellFE has talent and traffic
team presence
Market sentiment
What the market is saying about CellFE
An AI-synthesized read of the highest-engagement posts about CellFE on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CellFE on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.